Form 4: Zimmer Biomet Executive Earns 7,050 Performance RSUs

Zimmer Biomet Holdings, Inc. Group President, Asia Pacific, Sang Yi, earned 7,050 performance-based Restricted Stock Units following the achievement of 2023-2025 performance targets.

Summary

• Sang Yi, Group President, Asia Pacific for Zimmer Biomet Holdings, Inc. (ZBH), earned 7,050 Restricted Stock Units (RSUs).
• These RSUs were performance-based, granted on March 6, 2023, and September 1, 2023, with the number earned determined by performance during the 2023-2025 period.
• Based on actual performance, 5,298 RSUs were earned from the March grant and 1,752 RSUs from the September grant, totaling 7,050 RSUs.
• Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
• The earned RSUs are scheduled to vest on March 6, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as the successful earning of performance-based RSUs indicates that the company met its internal performance targets, which is generally a good sign for investors.

Positives

• The reporting person earned 7,050 performance-based RSUs, indicating that the company's performance conditions for the 2023-2025 period were met.
• This aligns the executive's compensation with company performance and shareholder interests.

Future Outlook

The earned Restricted Stock Units are scheduled to vest on March 6, 2026, at which point they will convert into shares of Zimmer Biomet Holdings, Inc. common stock.

Industry Context

StockSavvy.ai notes that this Form 4 filing is a routine disclosure of executive compensation, specifically the outcome of a performance-based RSU grant. Such disclosures are common across publicly traded companies as part of their long-term incentive plans, aligning executive interests with shareholder value creation.

Comparison to Industry Standards

• This Form 4 filing details an individual executive's RSU vesting and does not contain information suitable for a direct comparison to industry-wide compensation benchmarks or specific company performance metrics against competitors like Stryker, Johnson & Johnson (DePuy Synthes), or Smith & Nephew.

Stakeholder Impact

• Shareholders: The vesting of performance-based RSUs indicates that the company met its performance targets, which could be viewed positively.
• Employees (specifically Sang Yi): This represents a significant component of the executive's compensation, rewarding past performance.

Next Steps

• The 7,050 earned Restricted Stock Units will vest on March 6, 2026, converting into shares of Zimmer Biomet Holdings, Inc. common stock.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Performance-based compensation